NCOA4: An Immunomodulation-Related Prognostic Biomarker in Colon Adenocarcinoma and Pan-Cancer

Figure 5

Relationship between the NCOA4 expression and the patients’ disease-specific survival in various cancer types. (a) The forest plot of hazard ratios of NCOA4 in human pan-cancer. (b) DSS survival map of various cancer types. The significant results of Kaplan–Meier curves are listed. (c) The expression of NCOA4 in alive and deceased individuals with the aforementioned cancer types.

(a)

(b)

(c)